Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

62.93USD
2:12pm EDT
Price Change (% chg)

$0.12 (+0.19%)
Prev Close
$62.81
Open
$63.19
Day's High
$63.26
Day's Low
$62.80
Volume
323,912
Avg. Vol
1,003,618
52-wk High
$65.65
52-wk Low
$47.53

LLY.N

Chart for LLY.N

About

Eli Lilly and Company, discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products. The Company also has an animal health business segment. It manufactures and distributes its products through facilities in the United States, Puerto Rico, and 15 other countries. Its products are sold... (more)

Overall

Beta: 0.46
Market Cap (Mil.): $70,178.13
Shares Outstanding (Mil.): 1,117.31
Dividend: 0.49
Yield (%): 3.12

Financials

  LLY.N Industry Sector
P/E (TTM): 19.99 32.67 33.58
EPS (TTM): 3.14 -- --
ROI: 12.95 18.00 17.30
ROE: 20.43 18.64 18.05
Search Stocks

Lilly beats forecasts, vows to remain independent

- Eli Lilly and Co's quarterly revenue plunged due to generic competition for its Cymbalta depression drug and its Evista osteoporosis treatment, but cost controls helped earnings beat forecasts.

24 Jul 2014

BRIEF-Lilly says would not pursue tax inversions as "primary driver" of potential deals

July 24 - Eli Lilly and Co : * CFO, in conference call with investors, says company would not pursue tax inversions as "primary driver" of any

24 Jul 2014

CORRECTED-UPDATE 2-Lilly beats forecasts, vows to remain independent

(Corrects 10th paragraph to show Pfizer bought Warner Lambert, Pharmacia and Wyeth (not Pfizer)

24 Jul 2014

Spooked by probes, pharma executives ask: should I leave China?

SHANGHAI - China's crackdown on corruption in the pharmaceutical sector has frightened foreign executives so much that some fear they could be jailed and have asked their lawyers if they should leave the country for six months. Others are thinking of going for good.

12 Jun 2014

Spooked by probes, pharma executives ask: should I leave China?

* Charges against GSK's Mark Reilly shocked business community

12 Jun 2014

Sanofi, Lilly pursue Cialis over-the-counter approval

PARIS - Sanofi and Eli Lilly and Co have agreed to pursue regulatory approval for over-the-counter sales of erectile dysfunction treatment Cialis, the French and U.S. drugmakers said in a statement on Wednesday.

28 May 2014

Sanofi, Lilly pursue Cialis over-the-counter approval

PARIS, May 28 - Sanofi and Eli Lilly and Co have agreed to pursue regulatory approval for over-the-counter sales of erectile dysfunction treatment Cialis, the French and U.S. drugmakers said in a statement on Wednesday.

28 May 2014

UPDATE 1-A bitter pill as China crackdowns squeeze pharma margins

SHANGHAI, May 25 - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over.

26 May 2014

RPT-A bitter pill as China crackdowns squeeze pharma margins

(Repeats article first published on Sunday. No changes to text.)

25 May 2014

A bitter pill as China crackdowns squeeze pharma margins

SHANGHAI - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over.

24 May 2014

Competitors

  Price Change
Takeda Pharmaceutical Co Ltd (4502.T) ¥4,720 +18.50
Johnson & Johnson (JNJ.N) $103.10 -0.34
Pfizer Inc. (PFE.N) $29.50 +0.29
Novartis AG (NOVN.VX) CHF82.30 +0.10
Merck & Co., Inc. (MRK.N) $60.30 +0.10
Abbott Laboratories (ABT.N) $42.52 -0.28
Sanofi SA (SASY.PA) €83.39 +0.45
AstraZeneca plc (AZN.L) 4,449.00p -18.50
GlaxoSmithKline plc (GSK.L) 1,463.00p +15.50
Bristol-Myers Squibb Co (BMY.N) $50.18 -0.59

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks